Seprafilm – Adhesion Barrier
THERAPEUTIC CATEGORY: Absorbable Adhesion Barrier
COMPOSITION: Seprafilm Adhesion Barrier is a sterile, bioresorbable, translucent membrane composed of two chemically modified anionic polysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose (CMC).
THERAPEUTIC INDICATIONS: Seprafilm Adhesion Barrier is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce the incidence, extent and severity of postoperative adhesions between the uterus and surrounding structures such as tubes and ovaries, large bowl, and bladder.
DOSAGE AND ADMINISTRATION: Seprafilm should be applied to sites of potentially adhesiogenic tissue and organ structures in the abdomino-pelvic or thoracic cavity to serve as a temporary barrier separating opposing tissue surfaces.
Pregnancy and Lactation: This product is not recommended for use during pregnancy and avoidance of conception should be considered during the first complete menstrual cycle after use of Seprafilm Adhesion Barrier.
WARNINGS: Seprafilm Adhesion Barrier should not be wrapped directly around a fresh anastomotic suture or staple line whether or not the anastomosis is diverted. Seprafilm Adhesion Barrier is supplied sterile and must not be re-sterilized.
ADVERSE REACTIONS: The type and frequency of adverse events reported are consistent with events typically seen following surgery when used as directed.
DISCLAIMER: This information is provided for medical and scientific purpose. Please refer to full prescribing information of Seprafilm for the approved indications.